Safety and Efficacy of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes

Mise à jour : Il y a 4 ans
Référence : NCT00343980

Femme et Homme

Extrait

This trial is conducted in Asia, Europe and Oceania. The aim of this research study is to compare the efficacy of adding inhaled preprandial insulin to glimepiride compared to adding rosiglitazone to glimepiride for the treatment of type 2 diabetes and to verify its safety (hypoglycaemia, pulmonary function, body weight, insulin antibodies and side effects)


Critère d'inclusion

  • diabetes ,Diabetes Mellitus, Type 2


Liens